全文获取类型
收费全文 | 1396篇 |
免费 | 54篇 |
国内免费 | 4篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 63篇 |
妇产科学 | 11篇 |
基础医学 | 236篇 |
口腔科学 | 21篇 |
临床医学 | 133篇 |
内科学 | 210篇 |
皮肤病学 | 38篇 |
神经病学 | 88篇 |
特种医学 | 61篇 |
外科学 | 140篇 |
综合类 | 279篇 |
预防医学 | 65篇 |
眼科学 | 8篇 |
药学 | 54篇 |
1篇 | |
肿瘤学 | 43篇 |
出版年
2022年 | 9篇 |
2021年 | 19篇 |
2020年 | 13篇 |
2019年 | 9篇 |
2018年 | 20篇 |
2016年 | 11篇 |
2015年 | 31篇 |
2014年 | 28篇 |
2013年 | 34篇 |
2012年 | 40篇 |
2011年 | 40篇 |
2010年 | 68篇 |
2009年 | 53篇 |
2008年 | 58篇 |
2007年 | 60篇 |
2006年 | 59篇 |
2005年 | 51篇 |
2004年 | 69篇 |
2003年 | 46篇 |
2002年 | 48篇 |
2001年 | 52篇 |
2000年 | 35篇 |
1999年 | 47篇 |
1998年 | 28篇 |
1997年 | 32篇 |
1996年 | 34篇 |
1995年 | 18篇 |
1994年 | 25篇 |
1993年 | 10篇 |
1992年 | 18篇 |
1991年 | 13篇 |
1990年 | 21篇 |
1989年 | 23篇 |
1988年 | 30篇 |
1987年 | 16篇 |
1986年 | 27篇 |
1985年 | 18篇 |
1984年 | 18篇 |
1983年 | 22篇 |
1982年 | 17篇 |
1979年 | 20篇 |
1978年 | 15篇 |
1977年 | 12篇 |
1976年 | 11篇 |
1973年 | 13篇 |
1972年 | 13篇 |
1971年 | 12篇 |
1970年 | 14篇 |
1967年 | 12篇 |
1966年 | 9篇 |
排序方式: 共有1454条查询结果,搜索用时 15 毫秒
11.
12.
V G Tsuman V A Odinokova B V Agafonov A E Nalivkin L E Gurevich O P Sidorova Z I Cherkesova S Iu Fialkovski? 《Grudnaia i serdechno-sosudistaia khirurgiia / Ministerstvo zdravookhraneniia SSSR [i] Vsesoiuznoe nauchnoe obshchestvo khirurgov》1990,(10):68-72
Thymectomy was included in the complex of therapeutic measures in the management of generalized myasthenia in 41 children. Much attention was given to preoperative management in which plasmapheresis was applied along with the traditional methods. As a result, maximum compensation of the myasthenic disorders was achieved and spontaneous respiration was restored in 9 patients who were given artificial ventilation of the lungs before the operation. The authors describe the techniques of thymectomy and the changes found in the thymus during histological study. No complications occurred. All of the children were discharged from the clinic in an improved condition. The late-term results were studied in 38 children in follow-up periods of 6 months to 4 years. Marked stable improvement was recorded in 31 (77.5%) patients. 相似文献
13.
14.
15.
16.
Carlos R Ferreira Dillon Kavanagh Ralf Oheim Kristin Zimmerman Julian Stürznickel Xiaofeng Li Paul Stabach R Luke Rettig Logan Calderone Colin MacKichan Aaron Wang Hunter A Hutchinson Tracy Nelson Steven M Tommasini Simon von Kroge Imke AK Fiedler Ethan R Lester Gilbert W Moeckel Björn Busse Thorsten Schinke Thomas O Carpenter Michael A Levine Mark C Horowitz Demetrios T Braddock 《Journal of bone and mineral research》2021,36(5):942-955
Inactivating mutations in human ecto-nucleotide pyrophosphatase/phosphodiesterase-1 (ENPP1) may result in early-onset osteoporosis (EOOP) in haploinsufficiency and autosomal recessive hypophosphatemic rickets (ARHR2) in homozygous deficiency. ARHR2 patients are frequently treated with phosphate supplementation to ameliorate the rachitic phenotype, but elevating plasma phosphorus concentrations in ARHR2 patients may increase the risk of ectopic calcification without increasing bone mass. To assess the risks and efficacy of conventional ARHR2 therapy, we performed comprehensive evaluations of ARHR2 patients at two academic medical centers and compared their skeletal and renal phenotypes with ENPP1-deficient Enpp1asj/asj mice on an acceleration diet containing high phosphate treated with recombinant murine Enpp1-Fc. ARHR2 patients treated with conventional therapy demonstrated improvements in rickets, but all adults and one adolescent analyzed continued to exhibit low bone mineral density (BMD). In addition, conventional therapy was associated with the development of medullary nephrocalcinosis in half of the treated patients. Similar to Enpp1asj/asj mice on normal chow and to patients with mono- and biallelic ENPP1 mutations, 5-week-old Enpp1asj/asj mice on the high-phosphate diet exhibited lower trabecular bone mass, reduced cortical bone mass, and greater bone fragility. Treating the Enpp1asj/asj mice with recombinant Enpp1-Fc protein between weeks 2 and 5 normalized trabecular bone mass, normalized or improved bone biomechanical properties, and prevented the development of nephrocalcinosis and renal failure. The data suggest that conventional ARHR2 therapy does not address low BMD inherent in ENPP1 deficiency, and that ENPP1 enzyme replacement may be effective for correcting low bone mass in ARHR2 patients without increasing the risk of nephrocalcinosis. © 2021 American Society for Bone and Mineral Research (ASBMR). 相似文献
17.
I. G. Bogdanov V. T. Velichkov A. I. Gurevich P. G. Dalev Academician M. N. Kolosov V. P. Mal'kova I. B. Sorokina L. N. Khristova 《Bulletin of experimental biology and medicine》1977,84(6):1750-1753
The antitumor action of the substance blastolysin, the main components of which are glycopeptide fragments from the cell wall ofLactobacillus
bulgaricus, was studied. Blastolysin exhibits a specific antitumor effect against sarcoma S-180, leukemia P-388, plasmacytoma MOPC-315, adenocarcinoma AKATOL, melanosarcoma B-16, carcinoma LLC, and spontaneous tumors of mice. It has low toxicity, does not depress hematopoiesis, and in the character of its action on tumor tissue it differs essentially from known chemotherapeutic preparations.M. M. Shemyakin Institute of Bioorganic Chemistry, Academy of Sciences of the USSR, Moscow. Scientific-Production Laboratory of Biologically Active Substances, Sofia, Bulgaria. Translated from Byulleten' Éksperimental'noi Biologii i Meditsiny, Vol. 84, No. 12, pp. 709–712, December, 1977. 相似文献
18.
19.
20.